Personalizing Cancer Treatment “If you go beyond pancreas cancer to other cancer types, you need a combination therapy to target the tumor and to target the immune system,” he adds. “This is a strategy to be able to do that.” Treatments for cancers like PDAC that could be derived...
New Cancer Treatment Can Save Limbs; Medical Breakthrough Could Put End to AmputationsA PIONEERING cancer treatment that prevents patients from losing limbs to the disease has been developed by British experts.The technique involves cutting off the blood supply to legs or other limbs where tumours ...
Korea University Offers New Breakthrough for Hepatitis C to Improve Life Expectancy News provided by Korea University College of Medicine Aug 21, 2024, 08:33 ET Share this article Treatment with direct-acting antivirals improve liver-related clinical outcomes and reduce ...
New research has identified a potential treatment that could improve the human immune system’s ability to search out and destroy cancer cells within the body. Scientists have identified a way to restrict the activity of a group of cells that regulate the immune system, which in turn ...
140人 A new study has revealed a promising new treatment method for late-stage non-small cell lung cancer (NSCLC). The research, published in the Annals of Oncology, compared the efficacy and safety of two different treatments: nanoparticle polymeric micellar paclitaxel (pm-Pac) plus cisplatin ...
The development of drugs targeting Claudin 18.2 (CLDN18.2) has gained momentum, heralding new hope in gastric cancer treatment. On December 31, 2024, the targeted drug Zolbetuximab from Astellas received approval in China, marking it as the world's first and only approved CLDN18.2-targeted ...
The deal focuses on a novel small molecule KAT6A inhibitor, aimed at treating hormone-sensitive cancers. With breast cancer being the most prevalent and deadly cancer among women globally, the potential impact of this treatment is immense. The global breast cancer market is also on the rise, pr...
Longevity Breakthrough: New Treatment Extends Lifespan and Enhances Physical Function Researchers found that removing certain inflammation-causing cells from mice every month, starting in their middle age, not only extended their lifespans but also improved their heart health and overall physic...
Pfizer on 25th Nov 2019, announced that a new breakthrough therapy, LORVIQUA has been approved by Health Sciences Authority (HSA) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC), whose disease have progressed after treatment with...
Hepatitis C viral (HCV) infection is the underlying cause for chronic Hepatitis C (CHC), liver cirrhosis, and liver cancer or hepatocellular carcinoma (HCC). In 2019, over 2,90,000 people died of HCV-related diseases. Recent medical advancement made a new breakthrough tre...